Long term efficacy and safety of Fludarabine, Cyclophosphamide and Rituximab regimen followed by 90Y-ibritumomab tiuxetan consolidation for the treatment of relapsed grades 1 and 2 follicular lymphoma

Francesco Pisani, Rosa Sciuto, Maria Laura Dessanti, Diana Giannarelli, Ramy Kayal, Sandra Rea, Francesco Marchesi, Mirella Marino

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Long term efficacy and safety of Fludarabine, Cyclophosphamide and Rituximab regimen followed by <sup>90</sup>Y-ibritumomab tiuxetan consolidation for the treatment of relapsed grades 1 and 2 follicular lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences